The scientific basis for breast-cancer screening in the Netherlands;De wetenschappelijke basis van het bevolkingsonderzoek naar borstkanker in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 22, 2002, Pages 1034-1041

  De Koning, H J ^a   Fracheboud, J ^a   Verbeek, A L M ^a   Rutgers, E J Th ^a   Van Der Maas, P J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST DISEASE; CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; MASS SCREENING; NETHERLANDS; OUTCOMES RESEARCH; REVIEW;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MASS SCREENING; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIALS;

EID: 0036602722     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Geen bewijs voor effectiviteit borstkankerscreening
2. Borstkankerscreening onvoldoende effectief
3. Screening mammography - An overview revisited
4. Screening for breast cancer with mammography
5. Cochrane review on screening for breast cancer with mammography
6. The Edinburgh randomised trial of screening for breast cancer: Description of method
7. Evaluation of periodic breast cancer screening with mammography
8. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials
9. Assessment of nationwide cancer-screening programmes
10. Randomisation by cluster and the problem of social class bias
11. Effectiviteit van bevolkingsonderzoek naar borstkanker; sterftereductie in binnen- en buitenland
12. Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study
13. Canadian National Breast Screening Study-2: 13-Year results of a randomized trial in women aged 50-59 years
14. Prediction of the effects and costs of breast-cancer screening in Germany
15. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years
16. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials
17. An overview of the Swedish randomised mammography trials: Total mortality pattern and the representativity of the study cohorts
18. Noncancer deaths in white adult cancer patients
19. Advanced breast cancer and its prevention by screening
20. Advanced breast cancer: Use of resources and cost implications
21. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee
22. Is screening for breast cancer with mammography justifiable?
23. Some random-effects models for the analysis of matched-cluster randomised trials: Application to the Swedish two-county trial of breastcancer screening
24. Bevolkingsonderzoek naar borstkanker: Een tussenbalans
25. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
26. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8
27. Extra incidence caused by mammographic screening
28. Changes in use of breast-conserving therapy in years 1978-2000
29. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors